# Ascites fluid calprotectin level is highly accurate in diagnosing spontaneous bacterial peritonitis: a preliminary proof of concept prospective study

**Authors:** Wisam Sbeit, Basheer Maamoun, Subhi Azzam, Amir Shahin, Michal Carmiel-Haggai, Tawfik Khoury

PMC · DOI: 10.1007/s10238-023-01257-0 · Clinical and Experimental Medicine · 2024-01-28

## TL;DR

This study shows that measuring calprotectin in ascites fluid can accurately diagnose spontaneous bacterial peritonitis in patients with liver cirrhosis.

## Contribution

The study introduces ascitic calprotectin as a novel and highly accurate diagnostic marker for spontaneous bacterial peritonitis.

## Key findings

- Ascitic calprotectin levels were significantly higher in patients with SBP compared to those without.
- A calprotectin cut-off of >21 μg/mL achieved high sensitivity and specificity for SBP diagnosis.
- Calprotectin did not correlate with cirrhosis stage or prognosis.

## Abstract

Ascites is the most common complication of liver cirrhosis. Spontaneous bacterial peritonitis (SBP) is a common complication of ascites. The diagnosis is made by an ascitic fluid polymorphonuclear (PMN) cell count of ≥ 250/mm3. However, no other diagnostic test is present for the diagnosis of SBP. The aim of the study present study is to assess the diagnostic yield of ascitic calprotectin in SBP, and to explore whether it can predict disease stage. We performed a single center proof-of-concept prospective study including all patients with cirrhosis and ascites who underwent paracentesis. Overall, 31 patients were included in the study. Eight patients had SBP vs. 23 patients without SBP. Ascitic calprotectin level was 77.4 ± 86.5 μg/mL in the SBP group, as compared to 16.1 ± 5.6 μg/mL in the non-SBP group (P = 0.001). An ascitic calprotectin cut-off value of > 21 μg/mL was associated with sensitivity and specificity of 85.7% and 89.5%, respectively, with ROC of 0.947 (95% CI 0.783 to 0.997, P < 0.0001). Notably, ascitic calprotectin did not had a prognostic value in cirrhosis stage and prognosis. Ascitic calprotectin was highly accurate in the diagnosis of SBP. It can be a serve as adjunct for indefinite cases of SBP.

## Full-text entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}
- **Diseases:** liver disease (MESH:D008107), hepatorenal syndrome (MESH:D006530), cirrhosis (MESH:D005355), atrophy (MESH:D001284), SBP (MESH:D010534), variceal hemorrhage (MESH:D014648), hepatocellular carcinoma (MESH:D006528), end stage cirrhosis (MESH:D007676), bacterial peritonitis (MESH:D010538), Liver cirrhosis (MESH:D008103), NASH (MESH:D005235), inflammation (MESH:D007249), hepatopulmonary syndrome (MESH:D020065), portal hypertension (MESH:D006975), -Stage Liver Disease (MESH:D058625), gastrointestinal diseases (MESH:D005767), Spontaneous (MESH:D005598), inflammatory bowel diseases (MESH:D015212), Cirrhotic (MESH:D000094724), Ascites (MESH:D001201), infection (MESH:D007239), hepatic encephalopathy (MESH:D006501)
- **Chemicals:** glucose (MESH:D005947), creatinine (MESH:D003404), bilirubin (MESH:D001663)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10822801/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10822801/full.md

---
Source: https://tomesphere.com/paper/PMC10822801